A Single Center Retrospective Study: Efficacy and Platelet Preservation of Double Plasma Molecular Adsorption System Therapy by Membrane Separation Versus Centrifugal Separation in Acute‐on‐Chronic Liver Failure Patients With Hepatocellular Carcinoma
Journal of Clinical Apheresis · 2026
DOI: 10.1002/jca.70192 ↗At a glance
Journal article in Journal of Clinical Apheresis, 2026. Written by Guozhen Zhang and 9 co-authors. Institution: Department of Intensive Care Medicine, Tianjin Cancer Hospital Airport Hospital, Tianjin, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Acute-On-Chronic Liver Failure, Blood Platelets. 17 references.
Abstract (original language)
Hepatitis B virus (HBV) infection is a leading cause of hepatocellular carcinoma (HCC) and liver failure. The double plasma molecular adsorption system (DPMAS) reduces bilirubin and may create a therapeutic window for anti‐tumor therapy in HCC patients. Two plasma separation techniques are used: membrane‐based (MBS‐DPMAS) and centrifugal (CPS‐DPMAS), but no study has compared them specifically in HCC patients with acute‐on‐chronic liver failure (ACLF). This retrospective study included 203 HBV‐related HCC patients who received DPMAS without plasma exchange (93 MBS‐DPMAS, 110 CPS‐DPMAS), with citrate anticoagulation used in all cases. Bilirubin, liver enzymes, INR, and platelet count were compared between groups and before versus after treatment. Baseline characteristics were comparable. CPS‐DPMAS showed superior bilirubin reduction (TBIL: 184.60 vs. 220.05 μmol/L, p = 0.002; DBIL: 156.04 vs. 183.55 μmol/L, p = 0.004), whereas platelet count was significantly higher after MBS‐DPMAS than after CPS‐DPMAS (135.35 vs. 106.32 × 10 9 /L, p = 0.012). Both modalities decreased INR transiently, and only MBS‐DPMAS significantly reduced ALT, AST, and creatinine. In conclusion, both techniques effectively reduce bilirubin and decrease INR, but CPS‐DPMAS offers better bilirubin clearance while MBS‐DPMAS provides better platelet protection, suggesting that technique selection should be individualized.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Intensive Care Medicine, Tianjin Cancer Hospital Airport Hospital, Tianjin, China.
- Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Ca…
- Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for…
- Department of Intensive Care Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
ORCID profiles: Guozhen Zhang, QingPei Guan, YueYang Deng
Cite
APA
Zhang, G., Wu, Y., Li, X., Zheng, H., Guan, Q., Hao, B., Deng, Y., Zhang, H., Wang, J., & Xia, R. (2026). A Single Center Retrospective Study: Efficacy and Platelet Preservation of Double Plasma Molecular Adsorption System Therapy by Membrane Separation Versus Centrifugal Separation in Acute‐on‐Chronic Liver Failure Patients With Hepatocellular Carcinoma. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70192
Vancouver
Zhang G, Wu Y, Li X, Zheng H, Guan Q, Hao B, et al. A Single Center Retrospective Study: Efficacy and Platelet Preservation of Double Plasma Molecular Adsorption System Therapy by Membrane Separation Versus Centrifugal Separation in Acute‐on‐Chronic Liver Failure Patients With Hepatocellular Carcinoma. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70192
BibTeX
@article{Zhang2026,
author = {Zhang, Guozhen and Wu, Yalin and Li, Xia and Zheng, Hong and Guan, QingPei and Hao, BoWei and Deng, YueYang and Zhang, HaoXin and Wang, Jing and Xia, Rui},
title = {A Single Center Retrospective Study: Efficacy and Platelet Preservation of Double Plasma Molecular Adsorption System Therapy by Membrane Separation Versus Centrifugal Separation in Acute‐on‐Chronic Liver Failure Patients With Hepatocellular Carcinoma},
journal = {Journal of Clinical Apheresis},
year = {2026},
doi = {10.1002/jca.70192}
}
EUVIMED